{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:51:04Z","timestamp":1790941864229,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["20220313E05-0"],"award-info":[{"award-number":["20220313E05-0"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22183MFDS431"],"award-info":[{"award-number":["22183MFDS431"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cmi.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T17:36:47Z","timestamp":1702489007000},"page":"646-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach"],"prefix":"10.1016","volume":"30","author":[{"given":"Min Joo","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewon","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Jun","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliel","family":"Nham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Gu","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Bin","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.12.010_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cmi.2023.12.010_bib3","series-title":"Vaccines and Related Biological Products Advisory Committee meeting, January 26, 2023. FDA briefing document: future vaccination regimens addressing COVID-19","year":"2023"},{"key":"10.1016\/j.cmi.2023.12.010_bib4","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41591-021-01459-7","article-title":"Understanding COVID\u201319 vaccine hesitancy","volume":"27","author":"Machingaidze","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fphar.2020.00937","article-title":"A\u00a0snapshot of the global race for vaccines targeting SARS-CoV-2 and the COVID-19 pandemic","volume":"11","author":"Funk","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cmi.2023.12.010_bib6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/microorganisms10071450","article-title":"Viral vector vaccine development and application during the COVID-19 pandemic","volume":"10","author":"Deng","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.cmi.2023.12.010_bib7","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.12.010_bib10","series-title":"COVID-19 vaccines safety update","year":"2022"},{"key":"10.1016\/j.cmi.2023.12.010_bib11","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military","volume":"6","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cmi.2023.12.010_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2023.12.010_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case\u2013control study","volume":"175","author":"Lai","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41467-022-28068-3","article-title":"Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong","volume":"13","author":"Lai","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2023.12.010_bib17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2023.12.010_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2023.12.010_bib19","article-title":"Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: a phase 2 randomised clinical trial","volume":"29","author":"Hui","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.cmi.2023.12.010_bib20","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3346\/jkms.2021.36.e67","article-title":"Estimating baseline incidence of conditions potentially associated with vaccine adverse events: a call for surveillance system using the Korean National Health Insurance Claims Data","volume":"36","author":"Huh","year":"2021","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2023.12.010_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-023-01055-0","article-title":"Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barr\u00e9 syndrome?","volume":"28","author":"Zheng","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cmi.2023.12.010_bib22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.cmi.2023.12.010_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41569-021-00662-w","article-title":"Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms","volume":"19","author":"Heymans","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cmi.2023.12.010_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2213-2600(22)00059-5","article-title":"Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis","volume":"10","author":"Ling","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2023.12.010_bib25","article-title":"Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature","volume":"12","author":"Lane","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2023.12.010_bib26","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/eurheartj\/ehad339","article-title":"COVID-19 vaccination-related myocarditis: a Korean nationwide study","volume":"44","author":"Cho","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cmi.2023.12.010_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2352-4642(22)00244-9","article-title":"Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study","volume":"6","author":"Kracalik","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cmi.2023.12.010_bib28","doi-asserted-by":"crossref","first-page":"n1114","DOI":"10.1136\/bmj.n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"373","author":"Pottegard","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.12.010_bib29","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.3346\/jkms.2021.36.e197","article-title":"Predicted and observed incidence of thromboembolic events among Koreans vaccinated with ChAdOx1 nCoV-19 vaccine","volume":"36","author":"Huh","year":"2021","journal-title":"J\u00a0Korean Med Sci"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23006006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23006006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T08:41:04Z","timestamp":1729240864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23006006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1198743X23006006"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.12.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}